je.st
news
Tag: enter
MRI Interventions and Siemens Enter into Agreement to Commercialize Next Generation Software ...
2014-02-24 06:00:00| Industrial Newsroom - All News for Today
IRVINE, Calif., - MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion ...This story is related to the following:Imaging Software |
Tags: software
enter
agreement
generation
Blackbird Energy, Pennant Energy Enter Share Agreement
2014-02-20 10:15:00| OGI
Pennant shareholders will receive three Blackbird shares for every seven Pennant shares, Blackbird said.
Tags: enter
share
agreement
energy
Vuzix and xCon Partners Enter into Global Strategic Cooperation
2014-02-18 06:00:00| Industrial Newsroom - All News for Today
Partnership to provide focused offerings on industrial wearable computing applications for Smart Glasses<br /> <br /> ROCHESTER, N.Y. - Vuzix Corporation (OTCQB: VUZI), a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets, announced today that it has entered into a strategic cooperation with xCon Partners GmbH, a leading consulting and industrial wearable computing solution company. Under the strategic cooperation, xCon Partners ...This story is related to the following:Safety and Security EquipmentSearch for suppliers of: Industrial Computers |
Tags: enter
global
partners
strategic
Oil prices drop as refineries enter maintenance season
2014-02-13 01:00:00| Offshore Technology
Oil prices dropped yesterday on worries that the approaching of refinery maintenance season would reduce crude consumption.
Tags: enter
prices
maintenance
season
Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes
2014-02-10 14:43:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon. Language: English Contact: Merck Media InquiriesKim Hamilton, 908-423-6831orCaroline Lappetito, 267-305-7639orMerck Investor RelationsCarol Ferguson, 908-423-4465orSamsung Media InquiriesHongSeok Ji, +82-32-455-6102orSamsung Investor RelationsSungjoon Park, +82-32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
enter
agreement
develop
Sites : [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] next »